Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer

Abstract

The tumor microenvironment (TME) is the internal environment of malignant tumor progression, and the host antitumor immune response and normal tissue destruction occur in the TME. Tumor-infiltrating lymphocytes (TIL) is a crucial component of the TME and reflect the host antitumor immune response. The purpose of this study was to discuss the methodology for TIL evaluation and assess the prognostic value of TIL in gastric cancer. In total, we reviewed 1,033 gastrectomy cases between 2002 and 2008 at the Third Affiliated Hospital of Soochow University. To understand the prognostic value of TIL in gastric cancer (GC), TIL were assessed by optical microscopy, and verified by immunohistochemistry. There is no current consensus on TIL scoring in GC. In this study, we discussed a TIL evaluation system that includes an analysis of the amount and percentage of TIL in a tumor. Ultimately, 439 (52.7%) cases showed high levels of TIL and 394 (47.3%) cases had low levels. There was a statistically significant relationship among TIL, tumor size, histological grade, LN metastasis, nerve invasion, tumor thrombus, pTN stage, and WHO subtypes (p < 0.001, respectively). TILhi was a positive significant predictor of overall survival (OS) in Kaplan–Meier survival analysis (P < 0.001) and multivariate Cox regression analysis (HR = 0.431, 95% CI: 0.347–0.534, P < 0.001). After surgery, patients with malignant tumors underwent chemoradiotherapy according to standard therapeutic guidelines based on TNM stage. The TNM scoring system cannot reflect the full information of TME; therefore, TIL can be used as a diagnostic supplement. We constructed a nomogram model that showed more predictive accuracy for OS than pTN stage. In summary, this study proves that high levels of TIL are associated with a positive prognosis and that TIL reflect the protective host antitumor immune response.

Pretreatment peripheral neutrophils, lymphocytes and monocytes predict long-term survival in hepatocellular carcinoma

“…Moreover, lymphocytes are usually recruited to the tumor microenvironment and engage in cell-mediated tumor responses. Numerous data have revealed that tumor infiltrating lymphocytes are associated with patient outcomes in various types of cancer [50][51][52][53][54], and lymphocyte phenotypes are fundamental for antitumor immunity and prognosis [38]. Therefore, reduced tumor infiltrating and peripheral lymphocytes might be indicative of impaired host antitumor response and favorable tumor microenvironments for cancer progression and dissemination.…”

<p>Fibrinogen/Lymphocyte Count Ratio Can Be Used as a New Indicator of Prognosis in Patients with Hepatocellular Carcinoma After Radical Resection</p>

“…For patients with elevated FLR and poor prognosis, it is possible to select appropriate treatment methods based on the actual clinical conditions of the patients, such as consider the combined treatment of transarterial chemoembolization (TACE) + radiofrequency ablation (RFA) instead of surgical resection. 27 Furthermore, the application of different staging standards also has an impact on the prognosis of HCC patients. 28 The current international staging standards include Barcelona Clinic Liver Cancer (BCLC) staging system, Hong Kong Liver Cancer (HKLC) staging system, TNM staging system, etc.…”

Lactate dehydrogenase: a marker of diminished antitumor immunity

“…Several studies describe a correlation between tumor size and tumorinfiltrating lymphocytes, with lower numbers of effector T cells in larger tumors. [87][88][89][90] In urothelial cancer, checkpoint inhibitors are registered as first-line treatment for patients who are cisplatin-ineligible and have high tumor PD-L1 expression, and as second-line treatment for patients who progressed on chemotherapy. A large, phase III trial is now investigating the role of avelumab as maintenance treatment following completion of first-line chemotherapy in urothelial cancer (NCT02603432).…”